Breaking News

Tweet TWEET

//Correction: Peregrine Pharmaceuticals Not Affected by U.S. Supreme Court's Decision

 //Correction: Peregrine Pharmaceuticals Not Affected by U.S. Supreme Court's
                                   Decision

PR Newswire

LONDON, June 20, 2013

LONDON, June 20, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.



Although our release this morning mentioned last week's Supreme Court
decision, we erroneously included Peregrine Pharmaceuticals Inc. (NASDAQ:
PPHM) as being in the subsector impacted by the Supreme Court's decision
regarding human gene patents. Peregrine has no human gene patents, and is
therefore not affected by this decision.

Clarification of Industry Comments

Readers are advised that comments made about industries as a whole are meant
to provide a macro-economic view of the industry and may not affect all
companies within each sector or subsector equally, proportionally or even
similarly. Depending on the specific context and factors unique to each
individual situation, some companies may even observe inverse effects to the
industry or market as a whole.

Today's Market Conditions

We would also like to remind readers; shares in almost every industry today
and yesterday are tracking losses in the broader market, which are falling
sharply as the market further digests comments from Federal Reserve Chairman
Ben Bernanke on Wednesday and to a smaller extent, news of China's worsening
cash crunch.

Not Financial Advice

Remember, information we provide is just that, information and represents our
opinion only. We provide information on a best efforts basis, but this does
not replace your financial advisor or supplementary due diligence. For more
information on our compliance and research procedures, please refer to our
disclaimer below.

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE AAA Research Reports

Contact: Contact Number: +1(646)396-9126 (9:00 am EST - 01:30 pm EST)
 
Press spacebar to pause and continue. Press esc to stop.